Pulse Biosciences (PLSE) Receivables - Net (2021 - 2026)

Pulse Biosciences (PLSE) posted quarterly Receivables - Net of $274000.0 for Q4 2025, up 1726.67% quarter-over-quarter from $15000.0 in Q3 2025.

Pulse Biosciences (PLSE) Receivables - Net (2021 - 2026) Analysis & Trends

Pulse Biosciences' Receivables - Net history runs 3 years deep, the most recent figure standing at $274000.0 for Q4 2025.

In Q4 2025, Receivables - Net changed N/A year-over-year to $274000.0; the TTM figure through Dec 2025 stood at $274000.0 (changed N/A YoY), while the FY2025 annual figure was $274000.0, changed N/A from the prior year.
Receivables - Net for Q4 2025 stood at $274000.0, up from $15000.0 in the prior quarter.
The five-year high for Receivables - Net was $274000.0 in Q4 2025, with the low at $5000.0 in Q3 2022.
The 3-year median for Receivables - Net is $21000.0 (2022), against an average of $65142.9.
Peak annual rise in Receivables - Net reached 93.06% in 2022, while the deepest fall reached 93.06% in 2022.
Pulse Biosciences' Receivables - Net stood at $61000.0 in 2021, then sank by 91.8% to $5000.0 in 2022, then soared by 5380.0% to $274000.0 in 2025.
Business Quant data shows PLSE's Receivables - Net at $274000.0 in Q4 2025, $15000.0 in Q3 2025, and $5000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn
10	Pulse Biosciences	3.33 Bn	3.33 Bn	161,000.00

Download Data